Today: 21 May 2026
Broadcom stock (AVGO) in focus after Fidelity VMware settlement as Fed, Big Tech earnings loom
25 January 2026
2 mins read

Broadcom stock (AVGO) in focus after Fidelity VMware settlement as Fed, Big Tech earnings loom

New York, January 25, 2026, 16:25 EST — Market closed

  • On Friday, Broadcom shares ended down 1.7%, closing at $320.05.
  • Fidelity announced it has settled a lawsuit concerning access to VMware software, which is owned by Broadcom.
  • Investors are turning to Wednesday for the Fed’s decision and a busy lineup of megacap tech earnings.

Broadcom (AVGO.O) ended Friday at $320.05, slipping 1.7%. This marks the fourth straight session of losses, leaving the stock roughly 23% off its 52-week peak.

U.S. markets are closed on Sunday, but traders are gearing up for a busy week. The Federal Reserve is widely expected to keep rates on hold Wednesday. Around 20% of the S&P 500 will report earnings, with heavyweights like Apple, Microsoft, Meta Platforms, and Tesla among them. “It’s been a little bit of a short but steep roller-coaster ride,” said Yung-Yu Ma, chief investment strategist at PNC Financial Services Group. “Earnings are the driver,” added Chris Galipeau, senior market strategist at Franklin Templeton. Reuters

Fidelity Investments announced Friday it reached a settlement in a lawsuit accusing Broadcom of threatening to cut off access to VMware’s “virtualization” software—tools that allow companies to run multiple virtual servers on a single physical machine—and sought to dismiss the case. A Fidelity spokesperson confirmed Broadcom’s services would continue “uninterrupted,” though Broadcom did not immediately respond to requests for comment. The dispute arose after Broadcom’s 2023 acquisition of VMware and a product revamp that nudged customers toward more expensive bundles. Reuters

Broadcom slid as Wall Street finished mixed on Friday. The Dow dropped 0.58%, while the S&P 500 inched up 0.03%, and the Nasdaq rose 0.28%. Intel tumbled 14% after flagging supply constraints that are limiting its ability to keep pace with AI-driven demand for data-center chips, dragging down risk appetite late in the week.

Chip stocks showed mixed results. Nvidia gained roughly 1.5%, but Qualcomm dropped around 1.3%, pushing Broadcom into the group’s lagging ranks.

Broadcom is right at the heart of the AI boom, offering networking chips and custom processors for data centers. It also relies on VMware to expand its reach in enterprise software. This blend can be a double-edged sword: the stock often reacts sharply to cloud spending chatter and any hints that corporate IT budgets might be scaling back.

There’s a catch. Broadcom warned that a rising share of AI revenue could weigh on margins. CFO Kirsten Spears noted on the December earnings call that first-quarter gross margin would likely drop by “approximately 100 basis points” sequentially because of this. The company also revealed a $73 billion backlog set to ship over the next 18 months, though analysts flagged risks tied to customer concentration. Reuters

Fidelity’s lawsuit, though settled now, highlights how VMware contract renewals and pricing shifts can get complicated. If big clients start holding off on renewals, pushing for better deals, or moving workloads elsewhere, it could quickly alter the outlook for Broadcom’s software growth.

The next major event is set for Wednesday, January 28, when the Fed announces its policy decision. Investors will then turn to megacap tech earnings for clues about AI spending trends. Broadcom shares start trading again on Monday.

Stock Market Today

  • Bank of Montreal (TSX:BMO) Shows 22.7% Undervaluation After Strong Rally
    May 20, 2026, 7:04 PM EDT. Bank of Montreal (TSX:BMO) has surged 56.9% over the past year, prompting debate on its current value. Despite this strong performance, an Excess Returns valuation model estimates an intrinsic value of C$280.60 per share versus a market price of C$216.82, indicating a 22.7% discount and suggesting the stock is undervalued. Key metrics include a book value of C$119.17 per share, expected earnings per share (EPS) of C$15.61, and a 13% return on equity. Investors monitor its capital position, credit quality, loan growth trends, and sensitivity to interest rate changes. The stock's valuation score is low at 2 out of 6, highlighting some risks, but current models show potential for further upside amid evolving economic conditions.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
NextEra Energy stock price: NEE set for earnings-week test after insider sale filing
Previous Story

NextEra Energy stock price: NEE set for earnings-week test after insider sale filing

Zhongji Innolight (300308.SZ) stock: China’s new fund-favorite faces a Monday test after a 5.8% slide
Next Story

Zhongji Innolight (300308.SZ) stock: China’s new fund-favorite faces a Monday test after a 5.8% slide

Go toTop